Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

about

Immunotherapy for pancreatic cancer: present and future.

P2860

Q38673158-548072A4-799A-4F04-BD46-8FA50C955AE2

P2860

Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

Item

http://www.wikidata.org/entity/Q40161224

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

@en

type

Item

label

Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

@en

prefLabel

Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

@en

P1476

Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

@en

P2093

Ji-Bing Chen

http://www.w3.org/2001/XMLSchema#string

Juan-Juan Shi

http://www.w3.org/2001/XMLSchema#string

Ke-Cheng Xu

http://www.w3.org/2001/XMLSchema#string

Li-Zhi Niu

http://www.w3.org/2001/XMLSchema#string

Mao Lin

http://www.w3.org/2001/XMLSchema#string

Qiao Li

http://www.w3.org/2001/XMLSchema#string

Shu-Peng Liu

http://www.w3.org/2001/XMLSchema#string

Xin-An Long

http://www.w3.org/2001/XMLSchema#string

Yuan-Ying Yuan

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Cells of origin in cancer

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.

Epithelial mesenchymal transition and pancreatic tumor initiating CD44+/EpCAM+ cells are inhibited by γ-secretase inhibitor IX.

Current immunotherapeutic approaches in pancreatic cancer.

Cancer stem cell vaccination confers significant antitumor immunity

Chemotherapy for pancreatic cancer: from metastatic disease to adjuvant therapy.

P2888

s00432-015-1968-4

P304

1827-1833

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00432-015-1968-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25860618

http://www.w3.org/2001/XMLSchema#string

Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

about

P2860

P2860

Prospective study of the safety and efficacy of a pancreatic cancer stem cell vaccine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698